Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Amortization of Goodwill (2019 - 2024)

Pediatrix Medical (MD) reported Amortization of Goodwill of $154.2 million for Q2 2024, down 89.36% on a QoQ basis from $1.4 billion in Q3 2019.

Pediatrix Medical (MD) has 2 years of Amortization of Goodwill data on file, last reported at $154.2 million in Q2 2024.

  • Quarterly Amortization of Goodwill changed N/A year-over-year to $154.2 million in Q2 2024, while the trailing twelve-month figure through Sep 2024 was $154.2 million (down 89.36% YoY) and the FY2019 annual result came in at $1.4 billion, changed N/A from the prior year.
  • Amortization of Goodwill declined to $154.2 million in Q2 2024 per MD's latest filing, from $1.4 billion in the prior quarter.
  • Across five years, Amortization of Goodwill topped out at $154.2 million in Q2 2024 and bottomed at $154.2 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn
10 Pediatrix Medical 1.74 Bn 1.41 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2024 154.24 Mn
Jun 30, 2024 154.24 Mn
Sep 30, 2019 1.45 Bn
Sep 30, 2019 1.45 Bn